These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27309382)

  • 1. Past, Present, and Future of Augmentation of Monocyte Function in the Surgical Patient.
    Galbraith N; Walker S; Carter J; Polk HC
    Surg Infect (Larchmt); 2016 Oct; 17(5):563-9. PubMed ID: 27309382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of IκK-16 on lipopolysaccharide-induced impaired monocytes.
    Galbraith NJ; Manek S; Walker S; Bishop C; Carter JV; Cahill M; Gardner SA; Polk HC; Galandiuk S
    Immunobiology; 2018; 223(4-5):365-373. PubMed ID: 29126656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Significance and Challenges of Monocyte Impairment: For the Ill Patient and the Surgeon.
    Galbraith N; Walker S; Galandiuk S; Gardner S; Polk HC
    Surg Infect (Larchmt); 2016 Jun; 17(3):303-12. PubMed ID: 26958709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity.
    Wiltschke C; Krainer M; Wagner A; Linkesch W; Zielinski CC
    Exp Hematol; 1995 May; 23(5):402-6. PubMed ID: 7536681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis.
    Joshi I; Carney WP; Rock EP
    Front Immunol; 2023; 14():1130214. PubMed ID: 36825018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
    Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
    J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma.
    Flohé S; Lendemans S; Selbach C; Waydhas C; Ackermann M; Schade FU; Kreuzfelder E
    Crit Care Med; 2003 Oct; 31(10):2462-9. PubMed ID: 14530752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients.
    Rosenbloom AJ; Linden PK; Dorrance A; Penkosky N; Cohen-Melamed MH; Pinsky MR
    Chest; 2005 Jun; 127(6):2139-50. PubMed ID: 15947332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.
    Meisel C; Schefold JC; Pschowski R; Baumann T; Hetzger K; Gregor J; Weber-Carstens S; Hasper D; Keh D; Zuckermann H; Reinke P; Volk HD
    Am J Respir Crit Care Med; 2009 Oct; 180(7):640-8. PubMed ID: 19590022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study.
    Leentjens J; Kox M; Koch RM; Preijers F; Joosten LA; van der Hoeven JG; Netea MG; Pickkers P
    Am J Respir Crit Care Med; 2012 Nov; 186(9):838-45. PubMed ID: 22822024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.
    Kleinerman ES; Knowles RD; Lachman LB; Gutterman JU
    Cancer Res; 1988 May; 48(9):2604-9. PubMed ID: 3128401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass.
    Börgermann J; Friedrich I; Scheubel R; Kuss O; Lendemans S; Silber RE; Kreuzfelder E; Flohé S
    Thorac Cardiovasc Surg; 2007 Feb; 55(1):24-31. PubMed ID: 17285470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor, but not macrophage colony-stimulating factor, suppresses basal and lipopolysaccharide-stimulated complement factor production in human monocytes.
    Høgåsen AK; Hestdal K; Abrahamsen TG
    J Immunol; 1993 Sep; 151(6):3215-24. PubMed ID: 7690797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-modulation of granulocyte macrophage-colony stimulating factor receptor on monocytes during human septic shock.
    Pangault C; Le Tulzo Y; Tattevin P; Guilloux V; Bescher N; Drénou B
    Crit Care Med; 2006 Apr; 34(4):1193-201. PubMed ID: 16484916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes.
    Hamilton JA; Whitty GA; Royston AK; Cebon J; Layton JE
    Immunology; 1992 Aug; 76(4):566-71. PubMed ID: 1383133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte deactivation--rationale for a new therapeutic strategy in sepsis.
    Volk HD; Reinke P; Krausch D; Zuckermann H; Asadullah K; Müller JM; Döcke WD; Kox WJ
    Intensive Care Med; 1996 Oct; 22 Suppl 4():S474-81. PubMed ID: 8923092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An mRNA atlas of G protein-coupled receptor expression during primary human monocyte/macrophage differentiation and lipopolysaccharide-mediated activation identifies targetable candidate regulators of inflammation.
    Hohenhaus DM; Schaale K; Le Cao KA; Seow V; Iyer A; Fairlie DP; Sweet MJ
    Immunobiology; 2013 Nov; 218(11):1345-53. PubMed ID: 23948647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.